Establishing in France: A Strategic Guide for International Scientific Companies

France: An Attractive Yet Complex Innovation Ecosystem to Navigate

Establishing a presence in France represents a significant opportunity for international companies in the scientific, technological, and deeptech sectors. With a rapidly evolving innovation ecosystem, a dense territorial network, and strong national support for research, France attracts a growing number of foreign players each year.

However, this attractiveness comes with a challenge: understanding the administrative, regulatory, and cultural specificities of the French market. Many international companies underestimate the complexity of the steps required to establish themselves effectively and sustainably.

EphyX Neuroscience operates at the intersection of science and strategy. As experts in scientific consulting and strategic development, our role is to help innovative companies successfully navigate their establishment in France with method, precision, and impact.

Understanding the Foundations of the French Innovation Model

France’s innovation model is strongly supported by public policy. Research and development are encouraged through several key mechanisms: the Research Tax Credit (Crédit d’Impôt Recherche, CIR), Bpifrance funding programs, European initiatives supported by Business France, and calls for projects from the Ministry of Research.

Beyond these mechanisms, France stands out through a dense ecosystem of technological clusters, competitiveness hubs, and specialized incubators. Structures such as Paris-Saclay, Lyonbiopôle, Eurobiomed, and Biovalley France connect laboratories, startups, and large corporations.

For a foreign scientific company, this means two things: there are significant opportunities for funding and collaboration, but accessing them requires a clear understanding of how the ecosystem operates.

EphyX helps companies map relevant stakeholders, identify the most suitable funding mechanisms based on their technological maturity, and position their projects within the right innovation networks.

The Challenges of Establishing a Scientific Company in France

A company seeking to establish itself in France must navigate a combination of scientific, regulatory, and operational dimensions.

The first challenge is administrative. The process of creating a legal entity—choosing the appropriate structure, registration, taxation, social security systems, and intellectual property management—varies depending on status and investor nationality. Without local support, these processes can delay operational launch by several months.

The second challenge is regulatory and technical. Sectors such as biotechnology, neuroscience, medical devices, and health technologies are governed by specific regulations, including oversight from ANSM (the French National Agency for Medicines and Health Products Safety), INPI for patents, and ethical review bodies for clinical research.

The third challenge is relational and cultural. France places strong emphasis on scientific rigor, institutional credibility, and local integration. A foreign company must rapidly establish legitimacy with key stakeholders: laboratories, competitiveness clusters, universities, and investors.

EphyX acts as a strategic facilitator. We support companies in understanding regulatory frameworks, connecting with the right stakeholders, and building a solid foundation for both scientific and operational integration.

The Role of Specialized Support: The EphyX Method

Establishing a scientific company in France is not merely an administrative process—it is a strategic scientific and entrepreneurial project in its own right.

Our approach is structured around three pillars: preparation, integration, and valorization.

We begin with a preparatory audit phase: analysis of the business model, understanding of scientific objectives, and identification of human and technical needs. This step allows us to determine the most appropriate legal structure (subsidiary, independent entity, or partnership model) and the financial mechanisms that can be mobilized from the outset.

This is followed by the operational integration phase. EphyX designs a tailored establishment pathway, typically over a period of three to six months. This includes introductions to specialized incubators, research clusters, and local authorities. We also support the preparation of initial funding applications—Bpifrance, regional programs, Horizon Europe, and onboarding mechanisms such as the French Tech Visa.

Finally, we focus on scientific valorization and visibility. Even a strong international project must quickly demonstrate its relevance and impact within the French ecosystem. We support clients in presenting their work, publishing in the right channels, developing appropriate scientific communication materials, and building long-term relationships with the academic community.

This comprehensive approach positions EphyX as a unique partner, capable of bridging scientific excellence and market realities.

Case Study: A U.S. Neurotechnology Company

Consider a U.S.-based company specializing in brain-computer interfaces, aiming to establish a European subsidiary to expand research collaborations and access European funding.

Prior to its expansion, the company had a strong scientific foundation but no experience with European regulatory frameworks. With EphyX, a structured action plan was developed: regulatory compliance analysis, scientific communication strategy, integration into the Paris-Saclay neurotech ecosystem, and support in applying for Horizon Europe and Bpifrance Deeptech funding.

Within twelve months, the company not only established its French subsidiary but also secured academic collaborations with INSERM and CNRS, while accessing over €500,000 in cumulative public funding.

This example illustrates the value of strategic support: transforming administrative setup into genuine scientific and economic integration.

France as a Gateway to European Research and Innovation

Establishing operations in France provides access to one of Europe’s most interconnected scientific markets. Thanks to its central position, France offers direct access to major European programs such as EUREKA, Horizon Europe, and transnational initiatives in health, neuroscience, and biotechnology.

France also benefits from a unique talent ecosystem. Each year, more than 10,000 researchers earn PhDs, and the country hosts one of the highest concentrations of public and private laboratories working in close collaboration. For foreign companies, this represents a significant opportunity for recruitment, partnership, and development.

EphyX helps clients transform this environment into a strategic advantage. We facilitate connections with research centers, host laboratories, technology transfer offices, and investors—acting as a bridge between international innovation and the French scientific landscape.

Conclusion: Establishing Means Integrating

Successfully establishing a presence in France is not simply about setting up a subsidiary—it is about understanding an ecosystem, adopting its codes, and leveraging it for growth. France is not just a destination for science; it is an accelerator. The key lies in understanding its rules and opportunities.

EphyX Neuroscience supports international scientific companies at every stage of their integration: from strategic framing to network development, including financial and regulatory structuring. We believe that successful establishment rests on three foundations: understanding, connection, and trust.

Because beyond the process, establishing a presence means building roots. And that is where true success begins.

References and Useful Resources

• Bpifrance – Deeptech Programs and Support for Foreign Companies

• Business France – Soft Landing France & French Tech Visa

• French Ministry of Research and Higher Education – International R&D Investment Guide

• EuroQuity / Enterprise Europe Network France – European Partnerships and Innovation Networks